3-amino-5-[4-[(4-fluoro-2-pyridinyl)carbamoyl]phenyl]-2-pyrrolidin-2-ylimidazole-4-carboxamide
C20H20FN7O2 — CID 175076082
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-amino-5-[4-[(4-fluoro-2-pyridinyl)carbamoyl]phenyl]-2-pyrrolidin-2-ylimidazole-4-carboxamide
3-amino-5-[4-[(4-fluoro-2-pyridinyl)carbamoyl]phenyl]-2-pyrrolidin-2-ylimidazole-4-carboxamide (PubChem CID 175076082) has the molecular formula C20H20FN7O2 and a molecular weight of 409.43 g/mol. Its IUPAC name is 3-amino-5-[4-[(4-fluoro-2-pyridinyl)carbamoyl]phenyl]-2-pyrrolidin-2-ylimidazole-4-carboxamide.
Molecular Properties
| Compound Name | 3-amino-5-[4-[(4-fluoro-2-pyridinyl)carbamoyl]phenyl]-2-pyrrolidin-2-ylimidazole-4-carboxamide |
|---|---|
| PubChem CID | 175076082 |
| Molecular Formula | C20H20FN7O2 |
| Molecular Weight | 409.43 g/mol |
| Exact Mass | 409.17 |
| IUPAC Name | 3-amino-5-[4-[(4-fluoro-2-pyridinyl)carbamoyl]phenyl]-2-pyrrolidin-2-ylimidazole-4-carboxamide |
| SMILES | NC(=O)c1c(-c2ccc(C(=O)Nc3cc(F)ccn3)cc2)nc(C2CCCN2)n1N |
| InChI | InChI=1S/C20H20FN7O2/c21-13-7-9-25-15(10-13)26-20(30)12-5-3-11(4-6-12)16-17(18(22)29)28(23)19(27-16)14-2-1-8-24-14/h3-7,9-10,14,24H,1-2,8,23H2,(H2,22,29)(H,25,26,30) |
| InChIKey | FJKUHZFAHARKCG-UHFFFAOYSA-N |
| XLogP | 1.57 |
| TPSA | 140.95 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 409.43 |
| LogP ≤ 5 | 1.57 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175076082 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.